Fredrik Alpsten

Fredrik Alpsten is currently Chairman & Chief Executive Officer at Devyser AB and Trendx AB. The current roles also include Chairman at Personolig Almanacka Nordic AB, Devyser, Inc., Devyser Uk Ltd., Biovica International AB, and Prolight Diagnostics AB. Additionally, the current positions include Director at SmartSeq Srl, Pharmatheus AB, and Njuice AB. Former roles include President & Chief Executive Officer at Doxa AB from 2009 to 2011 and at Clinical Diagnostic Solutions, Inc. from 2012 to 2013.
Served as Chief Financial Officer & Deputy CEO at Irras AB from 2017 to 2019.
Chief Executive Officer at Devyser Diagnostics AB from 2020 to 2025.
Chairman at Personlig Almanacka Nordic AB. Finance Director at N&T Argonaut AB. Independent Director at Binero Group AB. Director at Boule Medical AB and Pharmetheus AB. Chief Financial Officer & Senior Vice President at Boule Diagnostics AB from 2011 to 2017.
Chief Financial Officer at AlgiPharma.
AS from 2019 to 2020.
Education includes undergraduate, graduate, and MBAistration degrees from Stockholm School of Economics.